86.21k followers • 22 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis
Well, that didn't take long -- the company's recently opened facility in Portugal is about to ship product. Meanwhile, MedMen comes up with its own delivery enhancement.
It looks like Molson Coors Brewing Company (NYSE:TAP) is about to go ex-dividend in the next 4 days. Investors can...
Today we're going to take a look at the well-established Anheuser-Busch InBev SA/NV (EBR:ABI). The company's stock saw...
Coverage on Cresco Labs has increased from seven analysts in July to nine in August. Six analysts favor a “strong buy,” and three recommend a “buy.”
New York’s Carolyn Maloney expressed optimism about the House approving the SAFE Banking Act. The bill would open banking access to the cannabis industry.
Bruce Linton, Canopy Growth's (CGC) (WEED) former co-CEO, has acquired more stock in the company. Overall, analysts favor a “buy” rating on the stock.
Cannabis stocks have been sinking lower and lower, but I would especially avoid CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) and two others.
Amgen (AMGN) markets Mvasi and Kanjinti, biosimilar versions of Avastin and Herceptin, respectively in the United States, and Kanjinti and Amgevita, biosimilar of Humira, in the EU.
Charlotte's Web has done a great job in the CBD hemp market thus far, but it may not make sense for other cannabis companies to try and follow suit.
Following the completion of a plan of arrangement, Aurora Cannabis (NYSE: ACB) (TSX: ACB) has acquired all of the issued and outstanding common shares of Hempco Food and Fiber (TSX-V: HEMP). To acquire shares of Hempco not already owned by Aurora, the company invested approximately C$63.4 million on a fully diluted basis. Hempco is now a wholly-owned subsidiary of Aurora. The […]The post Why Did Aurora Cannabis Acquire Hempco Food and Fibre? appeared first on Market Exclusive.
FDA approves AbbVie's (ABBV) upadacitinib to be marketed as Rinvoq. Bayer (BAYRY) is set to divest its Animal Health unit to Elanco for $7.6 billion in a cash-and-stock deal.